While this case provides valuable insights for identifying atypical GFAP antibody-associated astrocytopathy (GFAP-A) in complex clinical scenarios (e.g., comorbid T2DM and multiple infections), it is important to acknowledge its inherent limitations. The gene discussed is GFAP; the disease is type 2 diabetes mellitus.